Studies of Depressive Symptoms in Schizophrenia | The British Journal of Psychiatry | Cambridge Core (original) (raw)

Summary

Depression assessed by clinical examination and Hamilton rating scale was found in half of 37 untreated new acute schizophrenics, and in about a third of chronic schizophrenics who relapsed whether treated with depot injections (89) or not (79). A significant part of depressive illness in schizophrenics is thus not drug-related. However, depression was commoner in those on higher doses of depot neuroleptic (P <.05) or who showed extrapyramidal side effects (P <.001), suggesting that drugs can play a part. Patients maintained in remission on moderate doses of depot drug had the lowest prevalence of depression.

References

Alarcon, R. de & Carney, M. W. P. (1969) Severe depressive mood changes following slow release intramuscular fluphenazine injection. British Medical Journal, iii, 564–7.Google Scholar

Ayd, F. J. (1975) The depot fluphenazines: A reappraisal after ten years' clinical experience. American Journal of Psychiatry, 132, 491—500.Google Scholar

Bennett, I. F., Cohen, D. & Starer, E. (1954) Isoniazid in the treatment of the chronic schizophrenic patient. Archives of Neurology and Psychiatry, 71, 54—65.CrossRefGoogle ScholarPubMed

Brockington, I. F., Kendell, R. E., Kellett, J. M., Curry, S. H. & Wainwright, (1978) Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients. British Journal of Psychiatry, 133, 162–8.CrossRefGoogle ScholarPubMed

Bowers, M. B. & Astrachan, B. M. (1967) Depression in acute schizophrenic psychosis. American Journal of Psychiatry, 123, 976–9.CrossRefGoogle ScholarPubMed

Chouinard, G., Annable, L. & Serrano, M. (1975) Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients: A controlled study of drug interaction. Archives of General Psychiatry, 32, 1295—1307.CrossRefGoogle ScholarPubMed

Claude, H. (1930) Schizomanie à Forme Imaginative. L'Encephale, 25, 10.Google Scholar

Claude, H., Borel, S. & Robin, G. (1924) Deménce Précoce, schizomanie et schizophrenic. L'Encephale, 19, 45.Google Scholar

Cohen, S., Leonard, C. V., Farberow, N. L. & Shneidman, E. S. (1964) Tranquillizers and suicide in the schizophrenic patient. Archives of General Psychiatry, 11, 312–21.Google Scholar

Conrad, K. (1958) Die Beginnende Schizophrenic: Versuch einer Gestaltanalyse des Wahns. Thieme: Stuttgart. p 315.Google Scholar

Docherty, J. P., van Kammen, D. P., Siris, S. G. & Marder, S. R. (1978) Stages of onset of schizophrenic psychosis. American Journal of Psychiatry, 135, 420–6.Google Scholar

Donlon, P. T. & Blacker, K. H. (1973) Stages of schizophrenia decompensation and reintegration. Journal of Nervous and Mental Disease, 157, 200–8.CrossRefGoogle ScholarPubMed

Extein, I. & Bowers, M. B. (1975) The pharmacological meaning of successful antipsychotic-antidepressant combinations. Comprehensive Psychiatry, 16, 427–34.Google Scholar

Falloon, I., Watt, D. C. & Shepherd, M. (1978) A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychological Medicine, 8, 59—70.CrossRefGoogle ScholarPubMed

Farberow, N. L., Shneidman, E. S. & Calista, L. (1961) Suicide among schizophrenic mental hospital patients. In The Cry for Help (eds. Farberow, and Shneidman, ). New York: McGraw Hill.Google Scholar

Freeman, H. (1967) The therapeutic value of combinations of psychotropic drugs: A review. Psychopharmacological Bulletin, 4, 1—27.Google ScholarPubMed

Goldman, D. (1958) Marsilid for hospital psychiatry. Journal for Clinical and Experimental Psychopathology, Supplement 1, 80–5.Google Scholar

Hanlon, T. E., Nussbaum, K. & Wittig, B. (1964) The comparative effectiveness of amitriptyline, perphenazine and their combination in the treatment of chronic psychotic patients. Journal of New Drugs, 4, 52—60.CrossRefGoogle Scholar

Hanlon, T. E., Ota, K. Y. & Kurland, A. A. (1970) Comparative effects of fluphenazine, fluphenazine-chlordiazepoxide and fluphenazine-imipramine. Diseases of the Nervous System, 31, 171–7.Google ScholarPubMed

Hedberg, D. L., Houck, J. H. & Glueck, B. C. (1971) Tranylcypromine-trifluoperazine combination in the treatment of schizophrenia. American Journal of Psychiatry, 127, 1141–6.Google Scholar

Hirsch, S. R., Gaind, R., Rohde, P. D., Stevens, B. C. & Wing, J. K. (1973) Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. British Medical Journal, i, 633–7.Google Scholar

Johnson, D. A. W. (1973) The side-effects of fluphenazine decanoate. British Journal of Psychiatry, 123, 519–23.Google Scholar

Johnson, D. A. W. (1978) The prevalence and treatment of drug induced extrapyramidal symptoms. British Journal of Psychiatry, 132, 27—30.Google Scholar

Johnson, D. A. W. (1979) Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia. British Journal of Psychiatry, 135, 524–30.Google Scholar

Johnson, D. A. W. & Heather, B. B. (1974) The sensitivity of the Beck Depression Inventory to changes in symptomatology. British Journal of Psychiatry, 124, 184–5.Google Scholar

Johnson, D. A. W. & Mellor, V. (1977) The severity of depression in patients treated in general practice. Journal of the Royal College of General Practitioners, 27, 419–22.Google ScholarPubMed

Klein, D. F. & Davis, J. M. (1969) Diagnosis and Drug Treatment of Psychiatric Disorders. Baltimore: Williams and Wilkins. p 165.Google Scholar

Klein, D. F. & Fink, M. (1962) Psychiatric reaction patterns to imipramine. American Journal of Psychiatry, 119, 432–8.CrossRefGoogle ScholarPubMed

Klein, D. F. (1965) Behavioural effects of imipramine and phenothiazines. Biological Psychiatry, 7, 273–86.Google Scholar

Knights, A., Okasha, M. S., Salih, M. A. & Hirsch, S. R. (1979) Depressive and extrapyramidal symptoms and clinical effects: A trial of fluphenazine versus flupenthixol in maintenance of schizophrenic outpatients. British Journal of Psychiatry, 135, 515–23.CrossRefGoogle Scholar

Kuhn, R. (1958) The treatment of depressive states with G22355 (imipramine hydrochloride). American Journal of Psychiatry, 115, 459–64.Google Scholar

Kurland, A. A., Hanlon, T. E. & Ota, K. Y. (1971) Combinations of psychotherapeutic drugs in the treatment of the acutely disturbed psychiatric patient. In Advances in Neuropsychopharmacology. Amsterdam: North Holland. p 419–24.Google Scholar

Leff, J. P. & Wing, J. K. (1971) Trial of maintenance therapy in schizophrenia. British Medical Journal, iii, 559—604.Google Scholar

MacKinnon, B. L. (1977) Postpsychotic depression and the need for personal significance. American Journal of Psychiatry, 134, 427–9.Google ScholarPubMed

Markowe, M., Steinert, J. & Heyworth-Davies, F. (1967) Insulin and chlorpromazine in schizophrenia: A ten year comparative study. British Journal of Psychiatry, 113, 1101–6.CrossRefGoogle Scholar

Mayer-Gross, W. (1920) Uber die stellungsnahme auf abgelaufenen akuten psychose. Zeitschrift fur die gsamte Neurologic und Psychiatrie, 60, 160—212.CrossRefGoogle Scholar

McGlashan, T. H. & Carpenter, W. T. (1976a) An investigation of the postpsychotic depressive syndrome. American Journal of Psychiatry, 133, 14—19.Google ScholarPubMed

McGlashan, T. H. & Carpenter, W. T. (1976b) Postpsychotic depression in schizophrenia. Archives of General Psychiatry, 33, 231–9.CrossRefGoogle ScholarPubMed

Michaux, M. H., Kurland, A. A. & Agallianos, D. D. (1966) Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of the newly hospitalized, acutely ill psychiatric patient. Current Therapeutics and Research, 8, 117–52.Google Scholar

Overall, J. E. and Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799—812.CrossRefGoogle Scholar

Paykel, E. S., Prusoff, B. A. & Uhlenhuth, E. H. (1971) Scaling of life events. Archives of General Psychiatry, 25, 340–7.CrossRefGoogle ScholarPubMed

Piskin, V. (1972) Concept identification and psychophysiological parameters in depressed schizophrenics as functions of imipramine and nialamide. Journal of Clinical Psychology, 28, 335–9.Google Scholar

Prusoff, B. A., Williams, D. H., Weissman, M. M. & Astrachan, B. M. (1979) Treatment of secondary depression in schizophrenia. Archives of General Psychiatry, 36, 569–75.CrossRefGoogle ScholarPubMed

Rifkin, A., Quitkin, F. & Klein, D. F. (1975) Akinesia, a poorly recognized drug-induced extrapyramidal behavioural disorder. Archives of General Psychiatry, 32, 672–4.Google Scholar

Rifkin, A. (1980) The risks of long-term neuroleptic treatment of schizophrenia: Especially depression and akinesia. Acta Psychiatrica Scandinavica, Supplement. .Google Scholar

Roth, S. (1970) The seemingly ubiquitous depression following acute schizophrenic episodes, a neglected area of clinical discussion. American Journal of Psychiatry, 127, 91–8.Google Scholar

Semrad, E. V. (1966) Long term therapy of schizophrenia. In Psychoneuroses and Schizophrenia (ed. Usdin, E. L.). Philadelphia: J. B. Lippincott. p 155.Google Scholar

Simpson, G. M., Amuse, D., Blair, J. P. & Farkas, T. (1964) Phenothiazine produced extrapyramidal system disturbance. Archives of General Psychiatry, 10, 199—208.CrossRefGoogle Scholar

Siris, S. G., van Kammen, D. P. & Docherty, J. P. (1978) Use of antidepressant drugs in schizophrenia. Archives of General Psychiatry, 35, 1368–77.CrossRefGoogle ScholarPubMed

Steinberg, H. R., Green, R. & Durell, J. (1967) Depression occurring during the course of recovery from schizophrenic symptoms. American Journal of Psychiatry, 124, 699—702.CrossRefGoogle ScholarPubMed

van Putten, T. & May, P. R. A. (1978) Akinetic depression in schizophrenia. Archives of General Psychiatry, 35, 1101–7.Google Scholar